Ovarian reserve of women with and without BRCA pathogenic variants: A systematic review and meta-analysis

Introduction: Preliminary clinical evidence suggests a detrimental effect of pathogenic variants of BRCA1 and 2 genes on fertility outcome. This meta-analysis evaluates whether women carrying BRCA mutations (BRCAm) have decreased ovarian reserve, in terms of Anti-Muellerian Hormone (AMH), compared t...

Full description

Bibliographic Details
Main Authors: Maria Luisa Gasparri, Rosa Di Micco, Veronica Zuber, Katayoun Taghavi, Giampaolo Bianchini, Serena Bellaminutti, Francesco Meani, Rossella Graffeo, Massimo Candiani, Michael D. Mueller, Andrea Papadia, Oreste D. Gentilini
Format: Article
Language:English
Published: Elsevier 2021-12-01
Series:Breast
Subjects:
AMH
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977621004628
id doaj-54d73027e7f04a6fbb8294f62e7eda69
record_format Article
spelling doaj-54d73027e7f04a6fbb8294f62e7eda692021-10-09T04:36:58ZengElsevierBreast1532-30802021-12-0160155162Ovarian reserve of women with and without BRCA pathogenic variants: A systematic review and meta-analysisMaria Luisa Gasparri0Rosa Di Micco1Veronica Zuber2Katayoun Taghavi3Giampaolo Bianchini4Serena Bellaminutti5Francesco Meani6Rossella Graffeo7Massimo Candiani8Michael D. Mueller9Andrea Papadia10Oreste D. Gentilini11Department of Gynecology and Obstetrics, Ospedale Regionale di Lugano EOC, via tesserete 46, 6900 Lugano, Switzerland; Faculty of Biomedical Sciences, Università della Svizzera Italiana, via Giuseppe Buffi 13, 6900, Lugano, SwitzerlandBreast Surgical Unit, San Raffaele University Hospital, Milan, Italy; Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, ItalyBreast Surgical Unit, San Raffaele University Hospital, Milan, ItalyInstitute of Social and Preventive Medicine, University of Bern, Bern, SwitzerlandDepartment of Medical Oncology, San Raffaele University Hospital, Milan, ItalyDepartment of Gynecology and Obstetrics, Ospedale Regionale di Lugano EOC, via tesserete 46, 6900 Lugano, SwitzerlandDepartment of Gynecology and Obstetrics, Ospedale Regionale di Lugano EOC, via tesserete 46, 6900 Lugano, SwitzerlandInstitute of Oncology of Southern Switzerland (IOSI) and Breast Unit of Southern Switzerland (CSSI), Bellinzona, SwitzerlandDepartment of Gynecology and Obstetrics, San Raffaele University Hospital, Milan, ItalyDepartment of Obstetrics and Gynecology, University Hospital of Bern and University of Bern, Bern, SwitzerlandDepartment of Gynecology and Obstetrics, Ospedale Regionale di Lugano EOC, via tesserete 46, 6900 Lugano, Switzerland; Faculty of Biomedical Sciences, Università della Svizzera Italiana, via Giuseppe Buffi 13, 6900, Lugano, Switzerland; Corresponding author. Università della Svizzera Italiana (USI), Department of Gynecology and Obstetrics, Ente Ospedaliero Cantonale, Ospedale Regionale di Lugano, Lugano, Switzerland.Breast Surgical Unit, San Raffaele University Hospital, Milan, ItalyIntroduction: Preliminary clinical evidence suggests a detrimental effect of pathogenic variants of BRCA1 and 2 genes on fertility outcome. This meta-analysis evaluates whether women carrying BRCA mutations (BRCAm) have decreased ovarian reserve, in terms of Anti-Muellerian Hormone (AMH), compared to women without BRCAm (wild-type). Material and methods: Systematic searches of PubMed, Medline, Scopus, Embase, Science Direct and the Cochrane Library from inception until July 2020 were conducted. All studies comparing AMH level in fertile age women, with and without BRCA pathogenic variants were considered. Sub-analyses were performed according to age, presence of breast cancer, and type of mutation. Results: Among 64 studies, 10 series were included. For the entire cohort, a trend of reduced AMH level were found between BRCAm carriers and women without pathogenic variants. BRCAm carriers aged 41-years or younger had lower AMH levels compared to 41-years or younger wild type women (OR: 0.73 [95%CI-1.12;-0.35]; p = 0.0002). This finding was confirmed for BRCA1m carriers (OR: 1 [95%CI-1.96;-0.05]; p = 0.004) whereas no difference was observed between BRCA2m carriers and wild type women. The same analysis on breast cancer patients with and without BRCAm achieved the same results. Conclusion: Young BRCA1m carriers seem to have lower AMH level compared with wild type women and therefore a potential decreased ovarian reserve.http://www.sciencedirect.com/science/article/pii/S0960977621004628AMHBreast cancerOvarian reserveBRCA1mBRCA2mBRCA pathogenic variants
collection DOAJ
language English
format Article
sources DOAJ
author Maria Luisa Gasparri
Rosa Di Micco
Veronica Zuber
Katayoun Taghavi
Giampaolo Bianchini
Serena Bellaminutti
Francesco Meani
Rossella Graffeo
Massimo Candiani
Michael D. Mueller
Andrea Papadia
Oreste D. Gentilini
spellingShingle Maria Luisa Gasparri
Rosa Di Micco
Veronica Zuber
Katayoun Taghavi
Giampaolo Bianchini
Serena Bellaminutti
Francesco Meani
Rossella Graffeo
Massimo Candiani
Michael D. Mueller
Andrea Papadia
Oreste D. Gentilini
Ovarian reserve of women with and without BRCA pathogenic variants: A systematic review and meta-analysis
Breast
AMH
Breast cancer
Ovarian reserve
BRCA1m
BRCA2m
BRCA pathogenic variants
author_facet Maria Luisa Gasparri
Rosa Di Micco
Veronica Zuber
Katayoun Taghavi
Giampaolo Bianchini
Serena Bellaminutti
Francesco Meani
Rossella Graffeo
Massimo Candiani
Michael D. Mueller
Andrea Papadia
Oreste D. Gentilini
author_sort Maria Luisa Gasparri
title Ovarian reserve of women with and without BRCA pathogenic variants: A systematic review and meta-analysis
title_short Ovarian reserve of women with and without BRCA pathogenic variants: A systematic review and meta-analysis
title_full Ovarian reserve of women with and without BRCA pathogenic variants: A systematic review and meta-analysis
title_fullStr Ovarian reserve of women with and without BRCA pathogenic variants: A systematic review and meta-analysis
title_full_unstemmed Ovarian reserve of women with and without BRCA pathogenic variants: A systematic review and meta-analysis
title_sort ovarian reserve of women with and without brca pathogenic variants: a systematic review and meta-analysis
publisher Elsevier
series Breast
issn 1532-3080
publishDate 2021-12-01
description Introduction: Preliminary clinical evidence suggests a detrimental effect of pathogenic variants of BRCA1 and 2 genes on fertility outcome. This meta-analysis evaluates whether women carrying BRCA mutations (BRCAm) have decreased ovarian reserve, in terms of Anti-Muellerian Hormone (AMH), compared to women without BRCAm (wild-type). Material and methods: Systematic searches of PubMed, Medline, Scopus, Embase, Science Direct and the Cochrane Library from inception until July 2020 were conducted. All studies comparing AMH level in fertile age women, with and without BRCA pathogenic variants were considered. Sub-analyses were performed according to age, presence of breast cancer, and type of mutation. Results: Among 64 studies, 10 series were included. For the entire cohort, a trend of reduced AMH level were found between BRCAm carriers and women without pathogenic variants. BRCAm carriers aged 41-years or younger had lower AMH levels compared to 41-years or younger wild type women (OR: 0.73 [95%CI-1.12;-0.35]; p = 0.0002). This finding was confirmed for BRCA1m carriers (OR: 1 [95%CI-1.96;-0.05]; p = 0.004) whereas no difference was observed between BRCA2m carriers and wild type women. The same analysis on breast cancer patients with and without BRCAm achieved the same results. Conclusion: Young BRCA1m carriers seem to have lower AMH level compared with wild type women and therefore a potential decreased ovarian reserve.
topic AMH
Breast cancer
Ovarian reserve
BRCA1m
BRCA2m
BRCA pathogenic variants
url http://www.sciencedirect.com/science/article/pii/S0960977621004628
work_keys_str_mv AT marialuisagasparri ovarianreserveofwomenwithandwithoutbrcapathogenicvariantsasystematicreviewandmetaanalysis
AT rosadimicco ovarianreserveofwomenwithandwithoutbrcapathogenicvariantsasystematicreviewandmetaanalysis
AT veronicazuber ovarianreserveofwomenwithandwithoutbrcapathogenicvariantsasystematicreviewandmetaanalysis
AT katayountaghavi ovarianreserveofwomenwithandwithoutbrcapathogenicvariantsasystematicreviewandmetaanalysis
AT giampaolobianchini ovarianreserveofwomenwithandwithoutbrcapathogenicvariantsasystematicreviewandmetaanalysis
AT serenabellaminutti ovarianreserveofwomenwithandwithoutbrcapathogenicvariantsasystematicreviewandmetaanalysis
AT francescomeani ovarianreserveofwomenwithandwithoutbrcapathogenicvariantsasystematicreviewandmetaanalysis
AT rossellagraffeo ovarianreserveofwomenwithandwithoutbrcapathogenicvariantsasystematicreviewandmetaanalysis
AT massimocandiani ovarianreserveofwomenwithandwithoutbrcapathogenicvariantsasystematicreviewandmetaanalysis
AT michaeldmueller ovarianreserveofwomenwithandwithoutbrcapathogenicvariantsasystematicreviewandmetaanalysis
AT andreapapadia ovarianreserveofwomenwithandwithoutbrcapathogenicvariantsasystematicreviewandmetaanalysis
AT orestedgentilini ovarianreserveofwomenwithandwithoutbrcapathogenicvariantsasystematicreviewandmetaanalysis
_version_ 1716830679352737792